Loading…
Back To Schedule
Thursday, June 18 • 5:00pm - 6:00pm
#536 OD: ON DEMAND - Microbiome Therapies Beyond Fecal Microbiota Transplantation: Challenges and Opportunities

Sign up or log in to save this to your schedule, view media, leave feedback and see who's attending!

Component Type: Session
Level: Intermediate

Live biotherapeutics, an emerging new class of drug products which leverage living microorganisms, have potential to prevent, treat or cure diseases or conditions. Leveraging next generation sequencing and other -omics technologies researchers are gaining a greater understanding of the human microbiome and the role it plays in human health, drug metabolism and disease. Experimentation with fecal transplants have shown promise in treating patients with C. difficile infection and IBD and researchers believe there are many more opportunities to significantly improve human health. This session will explore the unique challenges in developing this new class of precision medicines.

Learning Objectives

Explain the microbiome and how it is being used to develop a new class of personalized medicines; Describe the unique clinical development, requlatory, manufacturing, and quality challenges faced when developing live biotherapeutics and approaches to overcome these challenges..

Chair

Anita Nelsen

Speaker

Microbiome Therapies Beyond Fecal Microbiota Transplantation: Solutions to Address Challenges
Anmol Grover, PhD



Speakers
avatar for Anita Nelsen

Anita Nelsen

Senior Vice President, Translational Medicine, Parexel, United States
Anita is a pharmaceutical industry leader who has applied pharmacogenetic, human and molecular genetics research in drug discovery and development. As Head of Translational Medicine, Anita leads a global team of scientists who are recognized thought leaders and influencers in quantitative... Read More →
avatar for Anmol Grover

Anmol Grover

Clinical Strategy Consultant, Halloran Consulting Group
Anmol Grover has more than ten years of experience in biomedical research and over 5 years of experience in biopharma focused strategy consulting. At Halloran, he is dovetailing his bioscience research background with consulting experience in supporting clients in critical business... Read More →


Thursday June 18, 2020 5:00pm - 6:00pm EDT
TBD Virtual Event Horsham, PA 19044
  06: PreClin Dev-EarlyPhaseCR, Session